Jean-Claude Mongrenier
PharmD, MBA
  • President of Groupe ADC: Servi Doryl, Réseaumatique & Biolog
  • Former head of Ortho Clinical Diagnostics in France and Chiron Blood Testing in France

Our History

May 2003: Magnisense created by Baring Vostok Capital Partners and private investors.

2003 – 2006: Technical development carried out jointly by Petr Nikitin’s team in Moscow and Bertin Technologies in France for engineering.

June 2006: Second round of financing.

November 2006: Business development teams created both in Europe and in the USA.

September 2007: New patent application filed for a multiparametric magnetic immunoassay,  MIAplex™.

February 2008: Creation of Magnisense Biological Development Laboratory in Dardilly, France.

December 2008: Third round of financing.

2008 – 2009: Several external validation studies on-going with leading human and veterinary IVD players.